Abstract
Despite some confusing conclusions among recent findings from the TRAVERSE trial, the results should provide physicians with reassuring evidence to enable them to manage men with symptomatic testosterone deficiency with greater confidence.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
